Parents of teens with severe acne should expect two negative pregnancy tests before isotretinoin can start under iPLEDGE in 2026. iPLEDGE, the FDA safety program that controls how isotretinoin is prescribed and dispensed, still requires that pre-treatment testing occur in a medical setting. Isotretinoin is an oral prescription drug for patients aged 12 and older with severe recalcitrant nodular acne that has not responded to standard treatment. FDA describes it as a known teratogen, which means it can harm an unborn child, in its Joint Advisory Committee briefing.
Medical information disclaimer: This article is for general educational purposes only and does not provide medical advice, diagnosis, or treatment. Always consult a physician or other qualified health professional about symptoms, medications, tests, or treatment decisions.
Table of Contents
- What the two pre-treatment tests require
- What changed in 2026, and what did not
- Why the starting rules stay strict
- How parents can plan the month before treatment
What the two pre-treatment tests require
Patients who can become pregnant must have two negative pregnancy tests before starting treatment. The confirmatory second test must occur during the first five days of the menstrual cycle right before therapy starts. That test follows 30 days of contraception or abstinence.
FDA states this sequence in its Joint Advisory Committee briefing. For parents, the timing matters. The start date depends on the menstrual cycle, not just the dermatology visit.
What changed in 2026, and what did not
FDA's shared-system listing shows a February 9, 2026 update, reflecting approved 2026 changes with effects starting August 9, 2026. The update allows more flexibility after treatment begins, but it does not relax the starting rules.
According to the National Community Pharmacists Association, prescribers may allow at-home pregnancy testing during and after treatment, but pre-treatment testing must still occur in a medical setting, as reported in its summary of the FDA changes. Parents should therefore plan for clinic or lab visits before the first prescription.
Why the starting rules stay strict
First-trimester exposure can cause craniofacial, cardiac, thymic, and central nervous system malformations. It also raises the risk of spontaneous abortion and premature birth.
That risk explains the closed system around the drug. All patients must enroll in the iPLEDGE REMS, and only enrolled and activated prescribers and pharmacies may prescribe or dispense it.
How parents can plan the month before treatment
A teen who can become pregnant must commit to two contraception methods or 100 percent abstinence. That commitment starts one month before isotretinoin, continues during treatment, and continues for one month after the last dose.
Monthly testing and visits are also required. Practical steps help avoid delays: Parents who map these steps early give the teen a clearer path to starting on time and staying adherent through treatment.
- Confirm who will provide birth control counseling and document the chosen methods.
- Track the menstrual cycle so the second pre-treatment test falls within days one through five.
- Secure transportation and lab access for in-person pre-treatment tests.
- Review school, work, and travel schedules against monthly visit needs.
You Might Also Like
- Pretreatment Pregnancy Testing Under iPLEDGE in 2026: What Changed, What Did Not, and What Comes Next for Parents of Teens With Severe Acne
- Planned Home Pregnancy Testing Under the 2026 iPLEDGE Changes: A Source-Checked Briefing for Parents of Teens With Severe Acne
- Herbal Acne Trial Safety and Evidence Limits in 2026: Questions Teens With Inflammatory Acne Can Ask a Dermatologist